Pictet-spengler ligation for protein chemical modification
US-2015291699-A1 · Oct 15, 2015 · US
Method for removing acetaldehyde
US10660966B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10660966-B2 |
| Application number | US-201515532938-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 4, 2015 |
| Priority date | Dec 4, 2014 |
| Publication date | May 26, 2020 |
| Grant date | May 26, 2020 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
A method for removing or controlling or quantifying the presence of aldehydes, in particular acetaldehyde, is described. Such a method is useful in prolonging the shelf life of a pharmaceutical product.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method for quantifying, removing or controlling acetaldehyde formation in a pharmaceutical formulation comprising the step of combining an aldehyde scavenger with a pharmaceutical formulation, wherein the pharmaceutical formulation comprises a radioactive pharmaceutical and a pharmaceutically acceptable solvent, wherein the aldehyde scavenger has the following structure: 2. The method according to claim 1 , wherein the radioactive pharmaceutical is a positron emission tomography (PET) tracer. 3. The method according to claim 1 , wherein the radioactive pharmaceutical is a 18 F PET tracer. 4. The method according to claim 1 , wherein the radioactive pharmaceutical is elected from the group of compounds comprising: 5. The method according to claim 1 , wherein the solvent comprises an alcohol. 6. The method according to claim 5 , wherein said alcohol is selected from ethanol, isopropanol or a bioalcohol. 7. The method according to claim 6 , wherein said alcohol is ethanol.
Assignees
Inventors
Classifications
Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy (radiotherapy per se A61N5/10) · CPC title
- A61K51/082Primary
the peptide being a RGD-containing peptide · CPC title
- A61K51/0453Primary
having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole · CPC title
Peptides, e.g. proteins {, carriers being peptides, polyamino acids, proteins} · CPC title
- A61K47/42Primary
Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein (oligopeptides having up to five amino acids {A61K47/183}; polyamino acids A61K47/34) · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10660966B2 cover?
- A method for removing or controlling or quantifying the presence of aldehydes, in particular acetaldehyde, is described. Such a method is useful in prolonging the shelf life of a pharmaceutical product.
- Who is the assignee on this patent?
- Ge Healthcare Ltd
- What technology area does this patent fall under?
- Primary CPC classification A61K51/082. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue May 26 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).